Article Per Year (5 Year)
p-Index From 2019 - 2024
0.408
P-Index
This Author published in this journals
All Journal As-syifaa Jurnal Farmasi Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan
Rachmat Kosman
Fakultas Farmasi, Universitas Muslim Indonesia, Makassar
Biochemistry, Genetics & Molecular Biology Chemistry Health Professions Immunology & microbiology Medicine & Pharmacology

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
EVALUASI TINGKAT PENGETAHUAN OBAT ANTIDIABETES PADA MASYARAKAT DI DESA BONTOKASSI GOWA Bayu Putra; Rachmat Kosman; Andi Maulana Kamri Petta Lolo
As-Syifaa Jurnal Farmasi Vol 13, No 1 (2021): AS-SYIFAA JURNAL FARMASI
Publisher : Fakultas Farmasi UMI

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33096/jifa.v13i1.764

Abstract

Diabetes mellitus is one of disease caused by changes individual's lifestyle and is not in accordance with a healthy lifestyle. In addition, this is also caused by factors that cannot be ignored. Knowledge of the general public in rural areas is very minimal because of their ignorance about diabetes mellitus. The method used in this study is descriptive observational prospectively by providing a questionnaire to assess the level of knowledge of respondents and the use of diabetes medication. Data collection was carried out in two stages. As a result of this service activity, respondents who were given counseling actually experienced an increase in their understanding of diabetes. The data obtained were analyzed by statistical program with t-test analysis. This can be seen from the statistical results that there is an effect of p <0.05 on knowledge about diabetes, the use of antidiabetic drugs, the effectiveness of antidiabetic drugs, the quality of antidiabetic drugs, and adherence to taking antidiabetic drugs. With these changes, the importance of information on patients by pharmacists in the area is very important.
ANALISIS EFEKTIVITAS BIAYA PENGGUNAAN AMLODIPIN DIBANDINGKAN KAPTOPRIL PADA PASIEN HIPERTENSI DI RUMAH SAKIT UMUM DAERAH MAJENE PERIODE JANUARI HINGGA JUNI TAHUN 2019 Andi Maulana Kamri; Rachmat Kosman; Dian Rahayu
Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Vol 6 No 2 (2021): JIIS
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (189.941 KB) | DOI: 10.36387/jiis.v6i2.718

Abstract

Hypertension is a chronic disease that requires long-term treatment and high cost. The research aimed to determine a more cost-effective treatment between amlodipine and captopril in hypertensive patients at Majene Hospital from January to June 2019. The sampling technique was purposive sampling with a cross-sectional method. The data collection was obtained from medical records and direct medical costs of hypertensive patients who take amlodipine or captopril. The Mann-Whitney statistical test was performed to determine the significant difference between the treatment groups. The results showed that the Average Cost Effectiveness Rasio (ACER) value of the 5 mg amlodipine and 12.5 mg captopril groups was Rp. 4233.3 and Rp. 4904 with an Incremental Cost Effectiveness rasio (ICER) value of Rp. 1063.5. Meanwhile, the Average Cost Effectiveness Rasio (ACER) value of the 10 mg amlodipine and 25 mg captopril group was Rp. 3764,7 and Rp. 4875.1. In conclusion, amlodipine is more cost effective than captopril.
Co-Authors Andi Maulana Kamri Bayu Putra Dian Rahayu